The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...

If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

Kennedy has focused his healthcare crusade on his contention that American healthcare prioritizes treating chronic illnesses ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

As this teen gets ready to graduate high school, she contemplates how Covid-19 affected her generation and wonders what she ...

Alexandra Sifferlin, a health and science editor for Times Opinion, hosted a written conversation with the Opinion columnist ...

The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

While Vaxart can proceed with its study, fellow COVID-19 vaccine developers GeoVax and Novavax continue to be hamstrung by ...

Kennedy Jr., plans to require all new vaccines ... HHS focused its concerns on the coronavirus vaccine. Recently, the department considered whether to remove the COVID-19 vaccine from the ...